{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:03:05Z","timestamp":1792728185669,"version":"4.5.0"},"reference-count":38,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T00:00:00Z","timestamp":1529107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T00:00:00Z","timestamp":1529107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1111\/jcpt.12720","type":"journal-article","created":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T18:34:37Z","timestamp":1529174077000},"page":"829-835","source":"Crossref","is-referenced-by-count":7,"title":["Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments"],"prefix":"10.1155","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-2068","authenticated-orcid":false,"given":"T.","family":"Hirai","sequence":"first","affiliation":[{"name":"Department of Pharmacy; Tokyo Women's Medical University Medical Center East; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yamaga","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Tokyo Women's Medical University Medical Center East; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Tokyo Women's Medical University Medical Center East; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Tokyo Women's Medical University Medical Center East; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,16]]},"reference":[{"key":"10.1111\/jcpt.12720-BIB0001|jcpt12720-cit-0001","doi-asserted-by":"crossref","first-page":"f6008","DOI":"10.1136\/bmj.f6008","article-title":"Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis","volume":"347","author":"Wu","year":"2013","journal-title":"BMJ"},{"key":"10.1111\/jcpt.12720-BIB0002|jcpt12720-cit-0002","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12720-BIB0003|jcpt12720-cit-0003","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1111\/jcpt.12720-BIB0004|jcpt12720-cit-0004","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1755-5922.2010.00258.x","article-title":"Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"30","author":"Raebel","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1111\/jcpt.12720-BIB0005|jcpt12720-cit-0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcard.2008.08.011","article-title":"Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome","volume":"138","author":"Ueno","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1111\/jcpt.12720-BIB0006|jcpt12720-cit-0006","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/archinternmed.2009.284","article-title":"Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy","volume":"169","author":"Weinberg","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12720-BIB0007|jcpt12720-cit-0007","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12720-BIB0008|jcpt12720-cit-0008","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between serum potassium and outcomes in patients with reduced kidney function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12720-BIB0009|jcpt12720-cit-0009","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1592\/phco.21.11.940.34520","article-title":"Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis","volume":"21","author":"Ross","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12720-BIB0010|jcpt12720-cit-0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.116.07363","article-title":"Antihypertensive medications and the prevalence of hyperkalemia in a large health system","volume":"67","author":"Chang","year":"2016","journal-title":"Hypertension"},{"key":"10.1111\/jcpt.12720-BIB0011|jcpt12720-cit-0011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2169\/internalmedicine.55.5697","article-title":"Renal Insufficiency in concert with renin-angiotensin-aldosterone inhibition is a major risk factor for hyperkalemia associated with low-dose trimethoprim-sulfamethoxazole in adults","volume":"55","author":"Higashioka","year":"2016","journal-title":"Intern Med"},{"key":"10.1111\/jcpt.12720-BIB0012|jcpt12720-cit-0012","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/j.1875-9114.1995.tb02900.x","article-title":"Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome","volume":"15","author":"Mihm","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12720-BIB0013|jcpt12720-cit-0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12720-BIB0014|jcpt12720-cit-0014","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11598930-000000000-00000","article-title":"The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007","volume":"51","author":"McLeay","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12720-BIB0015|jcpt12720-cit-0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/jch.12658","article-title":"Relationships between blood pressure and 24-hour urinary excretion of sodium and potassium by body mass index status in Chinese adults","volume":"17","author":"Yan","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1111\/jcpt.12720-BIB0016|jcpt12720-cit-0016","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jcpt.12720-BIB0017|jcpt12720-cit-0017","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1373\/49.1.190","article-title":"Sex and age differences in serum potassium in the United States","volume":"49","author":"Wysowski","year":"2003","journal-title":"Clin Chem"},{"key":"10.1111\/jcpt.12720-BIB0018|jcpt12720-cit-0018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2125.1995.tb04463.x","article-title":"Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers","volume":"39","author":"Anderson","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12720-BIB0019|jcpt12720-cit-0019","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00228-015-1987-8","article-title":"Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults","volume":"72","author":"Webb","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12720-BIB0020|jcpt12720-cit-0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajh\/hpw003","article-title":"The role of aldosterone in obesity-related hypertension","volume":"29","author":"Kawarazaki","year":"2016","journal-title":"Am J Hypertens"},{"key":"10.1111\/jcpt.12720-BIB0021|jcpt12720-cit-0021","doi-asserted-by":"crossref","first-page":"005428","DOI":"10.1161\/JAHA.116.005428","article-title":"Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project","volume":"6","author":"Bandak","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1111\/jcpt.12720-BIB0022|jcpt12720-cit-0022","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ahj.2006.05.030","article-title":"Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials","volume":"152","author":"Denus","year":"2006","journal-title":"Am Heart J"},{"key":"10.1111\/jcpt.12720-BIB0023|jcpt12720-cit-0023","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/ki.1993.140","article-title":"Pathophysiology of low renin syndromes: sites of renal renin secretory impairment and prorenin overexpression","volume":"43","author":"Lush","year":"1993","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12720-BIB0024|jcpt12720-cit-0024","doi-asserted-by":"crossref","first-page":"488","DOI":"10.12998\/wjcc.v2.i10.488","article-title":"Diabetes mellitus and electrolyte disorders","volume":"2","author":"Liamis","year":"2014","journal-title":"World J Clin Cases"},{"key":"10.1111\/jcpt.12720-BIB0025|jcpt12720-cit-0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2125.1986.tb05205.x","article-title":"Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat","volume":"21","author":"Hockings","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12720-BIB0026|jcpt12720-cit-0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2125.2000.00103.x","article-title":"Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency","volume":"49","author":"Greenbaum","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12720-BIB0027|jcpt12720-cit-0027","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0091270006290333","article-title":"Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors","volume":"46","author":"LeBlanc","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jcpt.12720-BIB0028|jcpt12720-cit-0028","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00004872-200106001-00005","article-title":"Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil","volume":"19","author":"Bergmann","year":"2001","journal-title":"J Hypertens Suppl"},{"key":"10.1111\/jcpt.12720-BIB0029|jcpt12720-cit-0029","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cpdd.17","article-title":"Model-supported development of CS-8635: a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide","volume":"2","author":"Song","year":"2013","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1111\/jcpt.12720-BIB0030|jcpt12720-cit-0030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjcard.2011.10.027","article-title":"Frequency and predictors of hyperkalemia in patients \u226560\u00a0years of age with heart failure undergoing intense medical therapy","volume":"109","author":"Muzzarelli","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1111\/jcpt.12720-BIB0031|jcpt12720-cit-0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/phar.2051","article-title":"Incidence of and risk factors for severe adverse events in elderly patients taking angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers after an acute myocardial infarction","volume":"38","author":"Fang","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12720-BIB0032|jcpt12720-cit-0032","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2215\/CJN.03700410","article-title":"Damned if you do, damned if you don't: potassium binding resins in hyperkalemia","volume":"5","author":"Watson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/jcpt.12720-BIB0033|jcpt12720-cit-0033","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.jhh.1001808","article-title":"Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan","volume":"19","author":"Chrysant","year":"2005","journal-title":"J Hum Hypertens"},{"key":"10.1111\/jcpt.12720-BIB0034|jcpt12720-cit-0034","doi-asserted-by":"crossref","first-page":"d4366","DOI":"10.1136\/bmj.d4366","article-title":"Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial","volume":"343","author":"Slagman","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/jcpt.12720-BIB0035|jcpt12720-cit-0035","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12720-BIB0036|jcpt12720-cit-0036","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12720-BIB0037|jcpt12720-cit-0037","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","article-title":"Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population","volume":"45","author":"Huerta","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jcpt.12720-BIB0038|jcpt12720-cit-0038","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12720\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T14:37:40Z","timestamp":1720363060000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,16]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12720","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,16]]}}}